Saturn V Capital Management LP
Top Portfolio Positions
21 positions ·
$552,217,503 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ALMS |
Alumis Inc.
Healthcare
|
3,202,075 | $70,541,712 | 12.77% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
4,349,885 | $60,463,401 | 10.95% | |
| ABVX |
Abivax S.A.
Healthcare
|
542,696 | $60,429,199 | 10.94% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
824,532 | $47,913,554 | 8.68% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
1,201,402 | $33,939,606 | 6.15% | |
| IMMX |
Immix Biopharma, Inc.
Healthcare
|
3,693,585 | $33,648,559 | 6.09% | |
| CELC |
Celcuity Inc.
Healthcare
|
281,904 | $32,176,522 | 5.83% | |
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
162,961 | $30,807,777 | 5.58% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
449,926 | $28,768,268 | 5.21% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
6,456,646 | $26,665,947 | 4.83% |
Portfolio Trend
14 quarters · across all stocks
Holdings in ABVX
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $60,429,199 | 542,696 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $87,545,034 | 649,179 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $68,023,917 | 801,224 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,761,964 | 622,479 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,455,787 | 552,926 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,780,479 | 653,071 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,465,178 | 648,019 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,298,987 | 627,760 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,908,471 | 622,970 | Shares | Sole | 2024-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||